Literature DB >> 4344092

Interferon-inducing polycarboxylates: mechanism of protection against vaccinia virus infection in mice.

A Billiau, J J Muyembe, P De Somer.   

Abstract

The present study was undertaken to examine possible correlations between long-term protection of mice treated with polycarboxylates and infected with vaccinia virus, and the presence of subdetectable amounts of interferon in the tissues, as determined by tissue or organ resistance to replication of viruses. After a single dose of polycarboxylate, splenic resistance to virus replication could be detected. It persisted for 7 to 14 days, but no attempt was made to prove that it was due to subdetectable amounts of interferon. Whole-animal protection lasted longer than splenic resistance. Moreover, when different polycarboxylates and different virus strains were used, patterns of early protection were not correlated with those of splenic resistance. These data, as others presented earlier, suggest that, in addition to interferon, other antiviral mechanisms are stimulated by polycarboxylates.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4344092      PMCID: PMC422452          DOI: 10.1128/iai.5.6.854-857.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Interferon-stimulating and in vivo antiviral effects of various synthetic anionic polymers.

Authors:  T C Merigan; M S Finkelstein
Journal:  Virology       Date:  1968-07       Impact factor: 3.616

2.  Interferon production by the spleen of rats after intravenous injection of Sindbis virus or heat-killed Escherichia coli.

Authors:  P De Somer; A Billiau
Journal:  Arch Gesamte Virusforsch       Date:  1966

3.  Antiviral activity of an interferon-inducing synthetic polymer.

Authors:  P E Came; M Lieberman; A Pascale; G Shimonaski
Journal:  Proc Soc Exp Biol Med       Date:  1969-06

4.  Interferon required for viral resistance induced by poly I.poly C.

Authors:  T W Schafer; R Z Lockart
Journal:  Nature       Date:  1970-05-02       Impact factor: 49.962

5.  Role of the spleen in interferon production in mice.

Authors:  M J Fruitstone; B S Michaels; D A Rudloff; M M Sigel
Journal:  Proc Soc Exp Biol Med       Date:  1966 Aug-Sep

6.  Induction of circulating interferon by synthetic anionic polymers of known composition.

Authors:  T C Merigan
Journal:  Nature       Date:  1967-04-22       Impact factor: 49.962

7.  Antiviral activity of polyacrylic and polymethacrylic acids. II. Mode of action in vivo.

Authors:  P De Somer; E De Clercq; A Billiau; E Schonne; M Claesen
Journal:  J Virol       Date:  1968-09       Impact factor: 5.103

8.  Effect of interferon, polyacrylin acid, and polymethacrylic acid on tail lesions on mice infected with vaccinia virus.

Authors:  E De Clercq; P De Somer
Journal:  Appl Microbiol       Date:  1968-09

9.  Polyacetal carboxylic acids: a new group of antiviral polyanions.

Authors:  P Claes; A Billiau; E De Clercq; J Desmyter; E Schonne; H Vanderhaeghe; P De Somer
Journal:  J Virol       Date:  1970-03       Impact factor: 5.103

10.  Antiviral activity of chlorite-oxidized oxyamylose, a polyacetal carboxylic acid.

Authors:  A Billiau; J Desmyter; P De Somer
Journal:  J Virol       Date:  1970-03       Impact factor: 5.103

View more
  3 in total

1.  Suppression of extablished Friend virus leukemia by statolon: potentiation of statolon's leukemosuppressive activity by chlorite-oxidized oxyamylose.

Authors:  O S Weislow; E F Wheelock
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

Review 2.  Macromolecular therapeutics.

Authors:  Jiyuan Yang; Jindřich Kopeček
Journal:  J Control Release       Date:  2014-04-18       Impact factor: 9.776

3.  Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines.

Authors:  David J Gasper; Brandon Neldner; Erin H Plisch; Hani Rustom; Emily Carrow; Hirotaka Imai; Yoshihiro Kawaoka; M Suresh
Journal:  PLoS Pathog       Date:  2016-12-20       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.